Issue: January 2019
January 01, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
TiCAB
Issue: January 2019
Assessment of the safety and efficacy of ticagrelor (Brilinta, AstraZeneca) in patients undergoing CABG.
